This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Early Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
May 9-12, 2022 | In-Person + DigitalHynes Convention Center, Boston

Daniel Smith
Associate Principal Scientist at Merck


Daniel Smith is an associate principal scientist at Merck in Rahway, NJ working on preclinical and early phase product development in the small molecule analytical research and development department. He earned his Ph.D from the University of Delaware as a graduate research fellow working on peptide biomaterials at the National Cancer Institute in Frederick, MD. Prior to joining Merck, he worked at GlaxoSmithKline on automated testing platforms for solid dosage forms.

Agenda Sessions

  • Improving Oral Bioavailability of Poorly-Permeable Peptides